Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ECOR NASDAQ:EYE NYSE:SNN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$7.28+4.7%$5.52$4.47▼$19.49$53.99M0.8106,127 shs49,573 shsEYENational Vision$25.22-0.2%$21.35$9.56▼$25.51$1.99B1.272.09 million shs1.40 million shsSNNSmith & Nephew SNATS$29.60+0.9%$29.38$23.69▼$31.72$12.96B0.69821,697 shs557,478 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore-6.71%-2.11%+36.54%+16.22%+10.67%EYENational Vision+1.00%+2.14%+17.43%+121.00%+99.21%SNNSmith & Nephew SNATS-2.36%-1.33%+0.07%+14.14%+5.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationECORelectroCore3.3974 of 5 stars3.54.00.00.03.32.50.6EYENational Vision2.8417 of 5 stars2.32.00.03.33.30.80.0SNNSmith & Nephew SNATS2.8815 of 5 stars1.03.02.50.02.30.04.4Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECORelectroCore 3.00Buy$25.50250.52% UpsideEYENational Vision 2.56Moderate Buy$22.10-12.35% DownsideSNNSmith & Nephew SNATS 2.00Hold$28.00-5.39% DownsideCurrent Analyst Ratings BreakdownLatest SNN, ECOR, EYE, and WGB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2025EYENational VisionUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.007/8/2025EYENational VisionNational BanksharesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$30.007/8/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$17.00 ➝ $30.006/18/2025EYENational VisionBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $26.005/19/2025EYENational VisionBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetMarket Perform ➝ Market Perform$13.00 ➝ $19.005/12/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $17.005/9/2025EYENational VisionThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$13.00 ➝ $17.005/9/2025EYENational VisionCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$13.00 ➝ $21.005/8/2025EYENational VisionUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.005/8/2025EYENational VisionLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.005/1/2025SNNSmith & Nephew SNATSCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$27.00 ➝ $28.00(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECORelectroCore$26.46M2.04N/AN/A$1.13 per share6.44EYENational Vision$1.85B1.08$1.65 per share15.29$10.37 per share2.43SNNSmith & Nephew SNATS$5.81B2.23$3.11 per share9.52$12.04 per share2.46Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECORelectroCore-$11.89M-$1.56N/AN/AN/A-46.24%-149.04%-61.24%8/6/2025 (Estimated)EYENational Vision-$28.50M-$0.33N/A93.393.67-1.40%3.44%1.40%8/6/2025 (Estimated)SNNSmith & Nephew SNATS$412M$2.1613.7014.800.92N/AN/AN/A8/5/2025 (Estimated)Latest SNN, ECOR, EYE, and WGB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025ECORelectroCore-$0.32N/AN/AN/A$7.24 millionN/A8/6/2025Q2 2025EYENational Vision$0.12N/AN/AN/A$469.21 millionN/A5/7/2025Q1 2025ECORelectroCore-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million5/7/2025Q1 2025EYENational Vision$0.32$0.34+$0.02$0.18$510.30 million$510.32 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthECORelectroCoreN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/ASNNSmith & Nephew SNATS$0.893.01%N/A41.20%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECORelectroCoreN/A1.521.30EYENational Vision0.290.540.35SNNSmith & Nephew SNATS0.622.891.33Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECORelectroCore26.74%EYENational VisionN/ASNNSmith & Nephew SNATS25.64%Insider OwnershipCompanyInsider OwnershipECORelectroCore19.70%EYENational Vision2.70%SNNSmith & Nephew SNATS1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECORelectroCore507.42 million5.96 millionNot OptionableEYENational Vision13,41179.05 million76.92 millionOptionableSNNSmith & Nephew SNATS17,349437.97 million433.59 millionOptionableSNN, ECOR, EYE, and WGB HeadlinesRecent News About These CompaniesBrokerages Set Smith & Nephew SNATS, Inc. (NYSE:SNN) PT at $28.00July 12, 2025 | americanbankingnews.comSNN or ESLOY: Which Is the Better Value Stock Right Now?July 11, 2025 | zacks.comAre Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?July 11, 2025 | zacks.comAllspring Global Investments Holdings LLC Invests $335,000 in Smith & Nephew SNATS, Inc. (NYSE:SNN)July 11, 2025 | marketbeat.comSmith & Nephew SNATS (NYSE:SNN) Sees Large Volume Increase - Here's What HappenedJuly 9, 2025 | marketbeat.comCallan Capital LLC Takes Position in Smith & Nephew SNATS, Inc. (NYSE:SNN)July 9, 2025 | marketbeat.comSmith & Nephew SNATS, Inc. (NYSE:SNN) Receives Consensus Rating of "Hold" from AnalystsJuly 9, 2025 | marketbeat.comSmith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless optionJuly 7, 2025 | globenewswire.comSmith & Nephew SNATS, Inc. (NYSE:SNN) Shares Acquired by Oppenheimer Asset Management Inc.June 28, 2025 | marketbeat.comSNN Expands Orthopedic Portfolio With Advanced Tibia Nailing SystemJune 26, 2025 | zacks.comSNN vs. GEHC: Which Stock Is the Better Value Option?June 25, 2025 | zacks.comIs Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?June 25, 2025 | zacks.comSmith & Nephew SNATS (NYSE:SNN) Sees Unusually-High Trading Volume - Time to Buy?June 24, 2025 | marketbeat.comSmith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fracturesJune 24, 2025 | globenewswire.comScharf Investments LLC Sells 555,004 Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN)June 23, 2025 | marketbeat.comAjay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy OfficerJune 23, 2025 | globenewswire.comSmith+Nephew Stock May Gain From Strategic Deal With Standard HealthJune 20, 2025 | zacks.comSmith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UKJune 18, 2025 | globenewswire.comSmith & Nephew plc (NYSE:SNN) Sees Significant Increase in Short InterestJune 16, 2025 | marketbeat.comLorne Steinberg Wealth Management Inc. Boosts Position in Smith & Nephew plc (NYSE:SNN)June 16, 2025 | marketbeat.comPark Avenue Securities LLC Acquires Shares of 9,206 Smith & Nephew plc (NYSE:SNN)June 16, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionBy Dan Schmidt | July 2, 2025View Aeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionPalantir Gets Price Hike From Wedbush Amid High ValuationBy Chris Markoch | July 15, 2025View Palantir Gets Price Hike From Wedbush Amid High ValuationToast Stock: A Fast-Growing Mid-Cap Eyeing Further UpsideBy Ryan Hasson | July 1, 2025View Toast Stock: A Fast-Growing Mid-Cap Eyeing Further UpsideRobinhood Director Sells Millions, But HOOD Stock Eyes GainsBy Gabriel Osorio-Mazilli | June 19, 2025View Robinhood Director Sells Millions, But HOOD Stock Eyes GainsCrowdStrike Eyes Breakout as Cyber Threats Boost DemandBy Chris Markoch | June 24, 2025View CrowdStrike Eyes Breakout as Cyber Threats Boost DemandSNN, ECOR, EYE, and WGB Company DescriptionselectroCore NASDAQ:ECOR$7.28 +0.33 (+4.68%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.National Vision NASDAQ:EYE$25.22 -0.05 (-0.18%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Smith & Nephew SNATS NYSE:SNN$29.60 +0.27 (+0.90%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
